Aryl Hydrocarbon Receptor in Health and Disease
MedComm · 2025-11 · 6 (11)
DOI: 10.1002/mco2.70426 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 17.10.2025. Verfasst von Haonan Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanx…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The aryl hydrocarbon receptor (AhR) functions as a ligand‐dependent transcription factor, serving as a pivotal environmental sensor that significantly influences both physiological and pathological processes. The inactivated state of AhR is present in the cell cytoplasm and transfer into the nucleus upon activation by a variety of ligands. It subsequently regulates a variety of processes including cellular metabolism, organ and tissue development, and maintenance of immune homeostasis. Despite substantial advancements over the past decade, the mechanisms by which AhR specifically regulates immune cell function in response to environmental factors and influences disease progression remain not fully elucidated. This review systematically analyzes the basic structure and major signaling pathways of AhR, its physiological functions in maintaining organismal homeostasis and its mechanism of action on various types of immune cells, and their therapeutic potential in autoimmune diseases, inflammatory disorders, tumor microenvironment, and neurodegenerative diseases. Translating immune‐metabolic reprogramming mechanisms into clinical applications represents a pivotal challenge in AhR research. And this review integrates and analyzes the great potential of AhR as a pleiotropic therapeutic target for regulating immunity and treating a series of diseases, offering actionable frameworks for future exploration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanxi Hospital Taiyuan China.
- The Second People's Hospital of Liaocheng Liaocheng China.
- Academy of Medical Sciences Shanxi Medical University Taiyuan China.
ORCID-Profile: Huifeng Shang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, H., Fan, Y., Liu, J., Dong, S., Wen, B., Zhang, Y., Wang, X., Duan, X., Hu, Y., Yan, Z., Shang, H., & Jing, Y. (2025). Aryl Hydrocarbon Receptor in Health and Disease. MedComm, 6(11). https://doi.org/10.1002/mco2.70426
Vancouver
Li H, Fan Y, Liu J, Dong S, Wen B, Zhang Y, et al. Aryl Hydrocarbon Receptor in Health and Disease. MedComm. 2025;6(11). doi:10.1002/mco2.70426
BibTeX
@article{Li2025,
author = {Li, Haonan and Fan, Yufeng and Liu, Jizheng and Dong, Shumin and Wen, Bin and Zhang, Yunfei and Wang, Xiaocui and Duan, Xuemei and Hu, Ying and Yan, Ze and Shang, Huifeng and Jing, Yukai},
title = {Aryl Hydrocarbon Receptor in Health and Disease},
journal = {MedComm},
year = {2025},
volume = {6},
number = {11},
doi = {10.1002/mco2.70426}
}
EUVIMED